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INTRODUCTION 
 
The eukaryotic genome is assembled as a nucleoprotein 
complex known as chromatin which is a structural polymer  
consisting of positively charged histone proteins in addition 
to DNA. It provides a dynamic platform that controls all 
DNA-mediated processes within the nucleus. The basic unit 
of chromatin is the nucleosome that consists of 147 bp of 
DNA wrapping nearly twice around the octamer, containing 
two copies of each of core histones H2A, H2B, H3 and H4. 
Each nucleosome is separated by 10-16 bp linker DNA and 
this bead on a string arrangement constitutes a chromatin 
fiber of ~10 nm in diameter. Each core histone within the 
nucleosome contains a globular domain, which mediates 
histone-histone interactions and also bears a highly 
dynamic amino terminal tail approximately 20-35 residues 
in length and is rich in basic amino acids. These tails extend 
from the surface of the nucleosome. Histone H2A also has 
an additional ~37 amino acid, carboxy-terminal domain 
protruding from the nucleosome.  All histone proteins are 
modified inside the nucleus of the cell, but so far only a few 
modifications have been studied.  A fundamental tenet of 
biochemistry is that proteins are composed of 20 basic 
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building blocks. Given the limited range of chemical 
functionality present in the amino acid side chains, the 
diversity of protein structure and function is truly 
extraordinary. In reality, the situation is not very complex: 
nature uses several modifications of proteins to 
complement and expand its chemical repertoire. In fact, 
many distinct posttranslational modifications (PTMs) have 
been identified to date, and the number and variety of 
modifications increase continuously. Histones are subject to 
many PTMs including acetylation and methylation of lysines 
(K) and arginines (R), phosphorylation of serine (S) and 
threonines (T), ubiquitination, sumolyation and biotinylation 
of lysines as well as ADP ribosylation. These modifications 
are recognized by specific protein-protein modules and can 
regulate each other as well (Yap and Zhou, 2006). Recent 
findings have revealed that these histone tails do not 
contribute to the structure of individual nucleosomes or to 
their stability but play an important role in folding of 
nucleosomal arrays into higher order chromatin structure  
(Paterson and Laniel, 2004). Eukaryotes have developed 
many histone-based strategies to introduce variation into 
the chromatin fiber because the chromatin is the 
physiological template for all DNA-mediated processes, and 
 6 
these strategies are likely to control the structure and/or 
function of the chromatin fiber. Two of the most common 
strategies employed are the PTMs of histones and 
replacement of major histone species by the variant 
isoforms  (Taverna et al., 2006).  Many studies have shown 
that the site-specific combinations of histone modifications 
correlate well with particular biological functions, such as 
transcription, silencing, heterochromatization, DNA repair 
and replication. These observations have led to the idea of a 
‘histone code’, although the degree of specificity of these 
codes may vary as particular combinations of histone marks 
do not always dictate the same biological function. 
Moreover, there is a clear indication that mistakes in PTMs 
may be involved in many human diseases, especially cancer 
(Somech et al., 2004).  
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Figura 1 Covalent marks on chromatin: Chromatin consists 
of repeated units of 146 bp of DNA wrapped 1.7 times around 
a octamer composed of two copies each of the four core 
histones; H2a, H2b, H3 and H4. Chromatin provides a 
structural platform that is subject to extensive post-
translational modification. These include methylation, 
acetylation, phosphorylation and ubiquitination of specific 
histone residues; methylation of CpG dinucleotides; exchange 
of histones (a); changes in the relative position of the 
nucleosome mediated by ATP-dependent remodelling 
complexes (b); induction of double-stranded DNA breaks by 
topoisomerase II (c) and the generation of single-stranded 
DNA breaks by topoisomerase I (d). 
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HISTONE MODIFICATIONS 
   
More than 35 years ago, it was noticed that transcriptionally 
active histones are acetylated in vivo, and this led to the 
speculation that covalent modifications of histones might 
have a role in determining the states of gene activity (Allfrey 
et al., 1964). The histone N-terminal tails, exposed on the 
nucleosome surface, are subject to a variety of enzyme-
catalyzed PTMs. As already mentioned, several histone-tail 
modifications have been identified. Moreover, each lysine 
residue can accept one, two or even three methyl groups, 
and similarly an arginine can be either mono- or 
dimethylated, which adds to the complexity. Although Strahl 
and Allis (2000) proposed the histone code, it’s not clear 
how the code is established and maintained till now. Many 
modification sites are close enough to each other and it 
seems that modification of histone tails by one enzyme 
might influence the rate and efficiency at which other 
enzymes use the newly modified tails as a substrate (Chung, 
2002).  The model proposed by Allis has set a ground for 
researchers to discover post-translational writers, the 
enzymes that modify the histones post translationally, and 
also the readers, the modules or motifs that recognize the 
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histones based on their modification state (Strahl and Allis, 
2000). Although the basic composition of the nucleosome is 
the same over long stretches of chromatin, the specific 
pattern of modifications on the nucleosome creates local 
structural and functional diversity, delimiting chromatin 
subdomains. Therefore, the challenge of histone PTMs has 
shifted from identifying sites of modification to identifying 
combinations of histone modification patterns that dictate 
specific biological readouts. Currently, the histone code is 
under a lot of investigation and is gaining experimental 
support as well.  Methylation of DNA at cytosine residues as 
well as PTMs of histones, including phosphorylation, 
acetylation, methylation and ubiquitylation, contributes to 
the epigenetic information carried by chromatin. These 
changes play an important role in the regulation of gene 
expression by modulating the access of regulatory factors 
to the DNA. The use of a combination of biochemical, 
genetic and structural approaches has been allowed to 
demonstrate the role of chromatin structure in 
transcriptional control. The structure of nucleosomes has 
been elucidated and enzymes involved in DNA or histone 
modifications have been extensively characterized. Because 
deregulation of epigenetic marks has been reported in many 
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cancers, a better understanding of the underlying molecular 
mechanisms bears the promise that new drug targets may 
soon be found.  
 
Acetylation  
Although it has been known for many years that histones in 
eukaryotes are modified by acetylation, it is only in the past 
decade that the role of histone acetylation in transcription 
regulation has been focused (Grunstein 1997, Kou and Allis, 
1998). Of all the histone modifications, acetylation is the 
most studied one. In the beginning, many of the enzymes 
responsible for acetylation of histones were known as 
transcriptional co-activators and later as enzymes. During 
specific biological processes, selected lysines such as lysine 
9 and 14 are acetylated. Acetylation of lysine residues at 
core histone N-terminal is achieved through enzymes called 
histone acetyltranferases (HATs).  However, the steady state 
balance of this modification is achieved using the 
orchestrated action of HATs and one more species of 
enzymes, namely histone deacetylases (HDACs) (Brownell 
and Allis, 1996; Kuo and Alis, 1998; Roth et al., 2000). 
There are two different types of HATs: type A-HATs, which 
are responsible for the acetylation of histones and are 
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directly involved in regulating chromatin assembly and gene 
transcription (Carrozza et al., 2003); type B-HATs, which 
are cytoplasmic proteins that catalyze histone acetylation in 
cytoplasm, particularly at lysine 5 and 12 of histone H4, 
prior histone incorporation into newly repli-cated chromatin 
(Parthun et al., 1996; Varreault et al., 1998). On the basis of 
sequence similarity, HATs can be organized into different 
families. These seem to display different mechanisms of 
histone substrate binding and catalysis. Some of the 
families are GNAT, PCAF, GCN5L, MYST etc. (Rosa and 
Caldas, 2005).  Human HDACs are grouped into three 
classes, HDACs I, II and III, which are based on their primary 
homology to the three HDACs of yeast. Class I HDACs  
(HDAC-1, -2, -3, -8 and -11) are homologous to yRPD3 
Class II HDACs are homologous to yHDA1 and are further 
subdivided into two subclasses IIa (HDAC-4, -5, -7 and -
9) and its splice variant MITR and IIb (HDAC-6 and  -10), 
which are based on their sequence homology and domain 
organization. Class III HDACs are homologous to ySIR2 of 
yeast and bear no homology to class I and II proteins 
(Verdin et al., 2003). HDACs are the components of large 
multiprotein complexes.   
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Methylation   
Histone methylation was first reported more than 40 years 
ago, yet this is among the least understood PTMs. In 
contrast to acetylation and phosphorylation, the lysine 
methylation relatively appears to be a stable histone 
modification. The most heavily methylated histone is H3 
followed by H4. Histone K methylation occurs on lysine 
residues 4, 9, 27 and 36 on H3 and on position 20 on H4.  
H1 amino terminus also seems to possess K methylation.  
Therefore, lysine methylation might be providing an ideal 
epigenetic mark for more long-term maintenance of 
chromatin states (Jenuwein and Allis, 2001). Histone 
methyltransferases (HMTs) are the enzymes that regulate 
the site-specific methylation of lysine residues, for example 
lysine 9 and lysine 4 in amino terminus of histone H3. It has 
been reported that the standard HMTs contain the 
evolutionary conserved 130 amino acid SET-domain and 
thereby stimulate some of the biological processes such as 
gene activation or repression (Jenuwein, 2001). There are 
two classes of methyltranferases depending on their 
specificity to either lysine (K-HMT) or arginine  (R-HMT) 
(Zhang and Reinberg, 2001). In addition a third class of 
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HMT has been described in yeast that affects the chromatin 
silencing, not by methylation of histone tails but instead 
targets a conserved lysine residue (K79) in the core domain 
of nucleosome (Khan and Hampsey, 2002). This is a product 
of DOT-1 (distrupter of telomeric silencing) gene, which is 
important for silencing (van Leeuwen et al., 2002). DOT-1 
doesn’t have a SET-domain and acts only when histone H3 
is packaged into the nucleosome. The HMT activity of DOT-
1 plays a direct role in telomeric silencing. As already 
mentioned, the extent of histone acetylation is determined 
by both acetyltransferases and deacetylases.  It is unclear 
whether histone methylation is also regulated by enzymes 
with opposing activities or in other words demethylases. Shi 
et al. (2004) provided evidence that LSD1  (KIAA 0601), a 
nuclear homolog of amine oxidases func-tions as a histone 
demethylase and transcriptional corepressor. LSD 1 
specifically causes demethylation of histone H3 lysine 4, 
which is linked to active transcription. Demethylases such 
as LSD1 and JHDM I mediate demethylation of di- and 
monomethylated histones (Whetsteinet al., 2006). However, 
it has been unclear whether demethylases that reverse 
lysine trimethylation exist. Whetstein et al.  (2006) have 
shown that JmjC domain containing protein  JMJD2A 
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reversed trimethylated H3-K9/K36 to dimethylated but not 
mono- or unmethylated products. In addition to this, JMJD2 
subfamily members also functioned as trimethylation-
specific demethylases, converting H3-K9Me3 to H3-K9Me2 
and H3-K9Me1. So, this family of demethylases generates 
different methylated states at the same lysine, and thereby 
provides a mechanism for fine-tuning histone methylation. 
An increasing number of histone demethylases are being 
discovered which highlights the dynamic nature of 
regulation of histone methylation, which is a key chromatin 
modification. These recent studies have offered glimpses 
into the specific biological role of demethylases and their 
potential connections to human diseases (Shi, 2007). 
Although methylation of histones was initially thought to be 
an activating or repressing type of modification, it seems to 
be much more sophisticated than thought initially (Berger, 
2007).   
 
Ubiquitination  
Histone ubiquitylation is emerging as one of the important 
modifications. Lys-123 within the carboxy terminal is a 
substrate for the Rad6 ubiquitin ligase in yeast. This 
modification has been found to be critical to mitotic and 
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meiotic growth. However, it is not clear whether it is 
involved in transcription (Robzyk et al., 2000).  
 
Biotinylation  
Recently, a novel PTM of histones has been identified, i.e, 
biotinylatin of lysine residue (Stanley et al., 2001).  The 
biotinylation or the binding of biotin to histones is 
catalyzed by biotinidase and holocarboxylase synthetase  
(HCS) (Narang et al., 2004; Sarath et al., 2004). Biotinidase 
uses biocytin (biotinyl-E-lysine) as a substrate for 
biotinylation of histones (Hymes et al., 1995), whereas HCS 
uses biotin and ATP (Narang et al., 2004). K4, K9 and K18 in 
histone H3 and K8 and K12 in histone H4 have been 
identified as the biotinylation sites (Camporeale et al., 2004; 
Sarath et al., 2004).  
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DNA METHYLATION 
 
DNA methylation is a covalent modification in which the 5’ 
position of citosine is methylated in a reaction catalyzed by 
DNA methyltransferases (DNMTs) with S-adenosyl-
methionine as the methyl donor. In mammals, this 
modification occurs at CpG dinucleotides and can be 
catalyzed by three different enzymes, DNMT1, DNMT3a and 
DNMT3b. DNA methylation plays a role in the long-term 
silencing of transcription and in heterochromatin formation. 
As an epigenetic modification, DNA methylation permits 
these silenced states to be inherited throughout cellular 
division. 
in the context of DNA methylation, sequences within the 
genome can be classified into two different groups: CpG 
poor regions and CpG island. CpG island are defined as 
being longer than 500 bp and having a CG content grater 
than 55% and an observed CpG/expected CpG ratio of 0.65 
(Takai and Jones, 2002).  
CpG islands are often, but not always found in promoter 
region and about 40% of gene contains CpG islands that are 
situated at the end of the 5’ region (promoter, untranslated 
region and exon I) (Jones and Baylin, 2002). The rest of the 
 17 
genome, such as the intergenic and the intronic regions, is 
considered to be CpG poor. In healthy cells, CpG poor 
regions are usually methylated whereas CpG islands 
aregenerally hypomethylated, with a few exeptions 
including the inactive X chromosome. During the 
development of cancer, many CpG islands undergo 
hypermethylation while the CpG poor regions become 
hypomethylated. This alteration in DNA methylation 
patterns leads to change in chromatin structure causing the 
silencing of tumor suppressor genes and instability of the 
genome (Jones and Baylin, 2002). This change in 
methylation pattern during cancer is similar to the pattern 
observed on the inactive X chromosome. The inactive X 
chromosome is hypermethylated at CpG promoter, but 
contain less methylation than the active X cromosome at 
CpG sites located downstream of the promoter (Jones, 
1999; Hellman and Chess, 2007). 
Traditionally, DNA methylation has been divided into two 
tipes: de novo and maintenance methylation. De novo 
methylation is catalyzed by DNMT3a and DNMT3band is 
important for the establishment of methylation patterns in 
early embryos, during development and during 
carcinogenesis (Okano et al., 1999). In order to maintain 
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these methylation patterns set by de novo methylation, 
DNMT1 is localized to the replication fork during cellular 
division and conduct maintenance methylation (Leonhard et 
al., 1999; Liu et al., 1998). However, DNMT1 has been 
shown to be inefficient at maintaining the methylation of 
many CpG dense regions (Liang et al., 2002). therefore, de 
novo activities of DNMT3a and DNMT3b are also necessary 
in somatic cells in order to reestabilish the methylation 
patterns so that they are no lost due to the inefficient 
activity of DNMT1. 
Although much progress has been made in understanding 
the role of DNA methylation plays in controlling cellular 
processes, there are still many details that are not fully 
understood.  
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GENE EXPRESSION AND SILENCING   
 
There are evidences showing that the modifications of 
histones gives signals that are recognized by specific 
binding proteins which in turn influence gene expression 
and other chromatid functions. Although this idea, when 
proposed, was a hypothesis around 30 years ago, now it is 
regarded as an established scientific fact (Turner et al., 
1992; Turner, 1993). The role of histone acetylation in 
transcription regulation has gained a lot of attention. The 
acetylation of lysine residues at core histone N-terminal 
weakens the interactions between core histones and DNA, 
which in turn destabilizes the nucleosomal structure and 
ultimately facilitates binding of transcription factors to DNA 
(Berger, 2002). However, such models, which suggest that 
acetylation of lysines will disrupt the histone DNA 
interactions and lead to open chromatin structure, do not 
have actually much evidence. For example, the histone H3 
tail contains 13 positively charged amino acids, and only 
one to four residues get acetylated, which will decrease the 
positive charge by 10%-30% that is unlikely to perturb the 
ionic interactions with DNA. In fact, the current view is that 
the histone marks by themselves may not alter the 
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nucleosomal dynamics.  There is a lot of evidence 
generating on the view that specific histone modifications 
control the binding of nonhistone proteins. In addition, 
several non-histone proteins such as HP1 or the PRC1 
polycom complex, not only bind to methylated histone 
lysines but also recruit the methylase itself and thus provide 
means for new histone methylation events. So, modified 
histone tails provide recognition sites for factors involved in 
either the activation or repression of gene expression. H3 
and H4 tails seem to be dominant players in chromatin fiber 
folding and also in intermolecular fiber-fiber interactions 
(Moore and Ausio, 1997; Tse and Hansen, 1997).  
Acetylation/deacetylation modifications of nucleosomal 
histones play a coordinated role in regulating gene 
expression. Hyperacetylation favors gene expression, 
whereas deacetylation by HDACs brings about silencing of 
the genes. Chen et al. (2002) have shown that histone 
acetylation significantly enhances the basal and the 
inducible expression of heat shock gene, hsp-70 in 
Drosophila melanogaster. It seems that when nucleosomes 
are at properly silenced genes, they may be stably 
hypoacetylated but there are several significant points of 
divergence from prevailing thinking. Clayton et al. (2006) 
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have found that for immediate early genes, which include 
many proto-oncogenes, it is not acetylation but turnover 
that seems to be necessary for efficient induction.  HDACs 
have been implicated as regulators of gene expression, 
especially during cell-differentiation and development. 
HDACs do not bind directly to DNA but seem to be recruited 
to specific promoters through their interaction with DNA 
sequence-specific transcription factors. By virtue of their 
ability to interact with distinct transcription factors that 
each bind at multiple sites in the genome, the HDACs seem 
to be master regulators controlling differentiation pathways 
(Verdin et al., 2003).  Researchers have used recombinant 
histone proteins to reconstitute the transcription system 
(reviewed by Lizuka and Smith, 2003). There is no doubt 
that the specific histones, templates, activators, and co-
activators used in these experimental systems are quite 
different, and the results are generally consistent with the 
importance of co-activator mediated histone modification in 
transcriptional activation (Lizuka and Smith, 2003). Agalioti 
et al.  (2002) have investigated the specificity of H3 and H4 
lysine  acetylation and the recruitment of specific co-
activators   for a specific gene Interferon-β (IFN-β). 
Nucleosomal template for this is reconstituted using 
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recombinant wild type and mutated histones as well as 
histone modifications in vitro. The tail lysines at the IFN-β 
promoter seem to be highly specific both in vivo and in vitro 
and marks three residues that are H4-K8, H3-K9 and H3-
K14. Using mutated and recombinant modified histones, 
researchers have demonstrated that these acetylations 
provide distinct signals for the sequential recruitment of 
bromodomain containing proteins BRG1, a component of 
SWItch/Sucrose NonFermentable (SWI/SNF) complex (a 
family of chromatin modifying complexes which has BRG1 
as the catalytic unit), and TAFII 250, a component of TFIID. 
Mutating H4-K8 lysine residue to alanine abolishes the 
ability to recruit BRG1 while mutating H3-K9 or K14 to 
alanine loses the ability to recruit TAFII 250. Therefore, the 
histone acetylation code for IFN-β promoter has been 
cracked  (Agalioti et al., 2002). Early experiments have 
suggested that H3-K4 methylation is linked to active genes, 
whereas H3-K9 was linked to inactive genes (Lachner and 
Jenuwein, 2002). However, Briggs et al. (2001) and Bryk et 
al. (2002) have shown that SET-1-mediated methylation of 
H3-K4 is involved in rDNA silencing in budding yeast, and 
H3-K4 methylation is seen in both active and silenced 
regions. For some time, this was little confusing how H3-K4 
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methylation can be associated with both activation and 
silencing of transcription. Recently, it has been shown using 
antibodies (that could distinguish between di- and 
trimethylated H3-K4) that trimethylation is specific for 
active state of transcription, whereas dimethylated K4 exists 
in both active and repressive genes (Rosa et al., 2002). So, it 
is evident that not only the particular site but also the 
number of methyl groups in a modification appears to play 
an important role in the functional consequences of histone 
methylation.  H3-K9 methylation characterizes repressed 
chromatin.  G9a is considered to be the major eukaryotic 
HMT responsible for demethylation of H3-K9 (H3K9me2) at 
transcriptionally active sites (Rice et al., 2003). G9a targets 
specific genes where it functions to repress transcription  
(Chen et al., 2006). Methylated H3-K9 provides a binding 
platform for heterochromatin protein 1 (HP1). In turn, HP1 
associates with a variety of other factors including suv39H1, 
HDACs, transcriptional repressors and chromatin 
remodeling enzymes (Hiragami and Festenstein, 2005).  
Smallwood et al. (2007) have tried to understand the 
relationship between HP1 family proteins and histone and 
DNA methyltransferases. In mammals, DNA methylation is 
controlled by DNMT1, DNMT3a and DNMT3b. DNMT3b 
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plays a role in the maintenance of methylation and DNMT1 
is involved in de novo methylation in specific cases. 
Smallwood and his colleagues focused on HMT G9a and 
DNMT1 and found that the HP1 family members directly 
interact with DNMT1. This interaction results in a functional 
stimulation of DNMT1 methyltransferase activity. HP1 is 
sufficient to target DNMT1 activity in vivo, and HP1 
dependently requires DNMT1. These researchers 
demonstrated that HP1 is recruited to the promoter of 
Survinin gene in a DNMT1-dependent manner. They support 
a model whereby HP1s mediate the cooperative silencing of 
DNA and HMTs. An emerging concept is that HATs and 
HDACs are housed in large multi-protein complexes. In 
addition, it seems that these complexes contain regulatory 
subunits that govern the enzyme-substrate specificity. 
Proteins that interact with HAT or HDAC may dictate 
whether the enzyme will either acetylate or deacetylate a 
specific site on a particular histone tail or on a nonhistone 
protein (Davie, 1998). Phosphorylation of histones H1 and 
H3 is known to play important roles in both transcriptional 
regulation and mitosis. Mutational dissection of 
phosphorylation sites in histone H1 provided the first 
evidence for functional regulation through a “charge patch”, 
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which has a localized concentration of positively or 
negatively charged amino acids (Dou and Gorovsky, 2000; 
Ren and Gorovsky, 2001). The phosphorylation of H1 
charge patch increases dissociation from the chromatin. 
Dou and Gorovsky (2002) have demonstrated that 
phosphorylation of H1 certainly increases its dissociation 
rate from chromatin in vivo. The researchers measured the 
dissociation rates of green flouresent protein (GFP)-tagged 
H1 constructs by fluorescence redistribution after 
photobleaching (FRAP) with a variety of mutations in the 
charge patch. H1 phosphorylation is lower in the G1 phase 
of the cell cycle, increases continually when the cells enter 
S-phase, and becomes hyperphosphorylated when 
chromosome condensation is maximal during mitosis and 
meiosis (Hohmann, 1983). Serines 10 and 28 on the histone 
H3 tail are both preceded by the same three amino acids, 
Alanine-Arginine-Lysine. Both of the two phosphorylatable 
motifs have been conserved throughout the evolution being 
identical in yeast and man (Allison et al., 2003). Mitotic 
phosphorylation of histone H3 on serine 10 (highly 
phosphorylated on condensed chromosomes during 
mitosis) is mediated by members of the aurora kinase 
family (a conserved family of enzymes that have multiple 
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kinase functions during meiotic progression), such as 
Aurora-A in Drosophila (Giet and Glover, 2001) and Aurora-
A and -B in mammals  (Crosio et al., 2002). Aurora-B also 
seems to mediate a mitotic serine 28 phosphorylation. In 
addition to this, stimulus-induced phosphorylation has also 
been seen and this also uses the same serine residues. This 
is transient, affects a minute fraction of nucleosomes and is 
associated with active genes (Allison et al., 2003).  
Biotinylation of histones is a new emerging field of research. 
Therefore, we do not have much information on the 
biological roles for biotinylation of histones (Kothapalli et 
al., 2005).  
The human genome project has revealed almost each gene 
within DNA but the regulation of gene expression in 
eukaryotes is still a matter of intensive research. Regulation 
of gene expression in eukaryotes is a multilevel hierarchical 
process. The cell has developed mechanisms to modify the 
chromatin organization and also to ensure that such 
organization is maintained through mitotic and meiotic cell 
divisions. There are four ways to achieve this: 1) chromatin 
remodeling factors; 2) posttranslational covalent 
modifications of histones; 3) replacement of canonical 
histones by histone variants; and 4) methylation at the C5 
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position of cytosine residues present in the CpG-islands by 
DNA methyl transferases (Rosa and Caldas, 2005). It is 
becoming quite evident that higher order chromatin 
structure, occurring via modifications of histones plays a 
crucial role in regulating gene expression. Inappropriate or 
altered gene expression might lead to disease states 
especially cancer. The acetylation of lysine residues creates 
new surface for protein association and give signals to 
many transcription factors and chromatin regulators to bind 
directly or indirectly to the acetylated histones. The 
acetylation of lysine residues seems to be crucial for cell 
proliferation. The HATs or HDACs have been found to be 
recruited by aberrant chimeric complexes to control 
abnormal gene expressions, for example, a fusion protein 
t(15;17) composed of PML-RAR in promyelocytic leukemia 
and another fusion protein AML1-ETD in acute  myeloid 
leukemia aberrantly recruit HDACs to target  genes leading 
to repression of otherwise active genes  (Amann et al., 
2001).  HDACs may also function in cancer development by 
more than one mechanism. An abnormal increase in HDAC 
activity may result in the transcriptional inactivation of 
tumor suppressor genes such as p53. HDAC4, HDAC8 and 
HDAC9 have been shown to express to a greater extent 
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(human) in tumor tissues than in normal tissues. Cancer 
promoting mutations and chromosomal translocation 
repress transcription through abnormal recruitment and 
activation of HDACs leading to neoplastic transformation. 
This has led to the idea of using HDACs inhibitors as a new 
class in cancer therapy. Several classes of HDAC inhibitors 
have been classified such as short-chain fatty acids for 
butyric acid, hydroxamic acids such as trichostation A (TSA) 
and cyclic tetra peptides with or without 2-amino-8-oxo-9, 
10 epoxy decanoyl  (AOE) and Benzamides such as MS-27-
275  (Neumeister et al., 2002).  
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Helicobacter pylori 
  
H. pylori is a bacterium that chronically colonizes the gastric 
epithelium and infects approximately half of the human 
population worldwide. This pathogen is responsible for 
chronic gastritis and a high percentage of peptic ulcers, and 
its presence has been correlated to gastric cancer 
development (Marshall et al., 1988; Parsonnet et al., 1991).  
Several factors have been associated with this germ’s 
aggressiveness and hence implicated in epithelial damage, 
including vacuolizing cytotoxin (VacA), cytotoxin-associated 
gene A (cagA), surface lipopolysaccharide (LPS), bacterial 
urease, flagella, surface adhesins, oxidizing radicals, and 
citokines produced by leukocytes in response to infection. On 
the other hand, there is increasing evidence that H. pylori 
species are genetically diverse, that such diversity is 
associated with different aggresiveness degrees on the 
mucosa, and hence with gastric mucosal inflammation to 
different extents and a variety of clinical prognoses for 
infected patients. H. pylori genoma includes more than 1,000 
preserved genes and strain-specific genes.  
This bacterium may acquire or lose exogenous DNA, and thus 
follows an ongoing microevolution model allowing high 
genetic variability, which may result in strains adapted to 
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multiple adverse environments. Such variability also results 
from a high recombination rate during colonization of one 
host by non-related H. pylori species, in addition to a high 
frequency of mutation ( Salama et al., 2000).  
Over the last few years, it has become apparent that the most 
important single factor responsible for the development of 
gastric cancer is H. pylori infection which affects more than 
50% of the world population.  The risk of patients with H. 
pylori infection developing gastric cancer is in the order of 
two- to sixfold according to most retrospective, case–control, 
and prospective epidemiological studies (Montecucco et al., 
2001.). However, if the selection of patients and methodology 
is optimized the risk increases to 20 times (Evans et al., 
2000.). H. pylori colonizes the gastric epithelium inducing an 
inflammatory reaction that may persist throughout the 
patient’s life despite a strong local immune reaction (Guruge 
et al., 1998). The extent and severity of gastric mucosal 
inflammation, as well as the clinical outcome of the infection 
depend on a number of factors including the virulence of the 
bacterium, host genetic susceptibility, immune response, age 
at the time of initial infection and environmental factors 
(Guruge et al., 1998). The complex interplay between these 
factors may explain why only a minority (<1%) of those 
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infected ultimately develop gastric cancer. 
The multistep process starts with H. pylori-related 
inflammatory reaction, thereafter progressing through a 
cascade of molecular and morphological changes (Ilver et al., 
1998). Histologically, gastric adenocarcinoma is prevalently 
divided into two types according to Lauren’s classification 
(Mizushima et al., 2001). The intestinal type consists of a 
gland-like structure that mimics the intestinal glands, and 
recognizes a series of precancerous lesions. The diffuse type, 
more prevalent in females younger than 50 years, lacks any 
glandular structure and arises closer to the advancing border 
of inflammation but without any identifiable histological 
precursor lesion (Pride et al., 2001). The intestinal and the 
diffuse types of gastric cancer both show an equally strong 
association with H. pylori infection. 
Exposure of gastric epithelial cells to H. pylori results in an 
inflammatory reaction with the generation of reactive oxygen 
species (ROS) and an increased level of nitric oxide (NO) 
synthase (Prinz et al., 2001;). NO synthase deaminates DNA 
and causes mutations, which may be the initial step in the 
genetic alterations of gastric epithelial cells (Ilver et al., 1998). 
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Figura 2 Model of H. pylori cell infection 
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Higher concentrations of 8-hydroxydeoxy-guanosine (8-OH-
dG), a wellknown marker of oxidative DNA stress, have been 
reported in H. pylori-positive patients with atrophic gastritis 
and intestinal metaplasia (IM). Furthermore, ROS and NO 
increase cell proliferation. The dynamic balance between cell 
proliferation and apoptosis is essential for maintaining normal 
mucosal integrity (Rad et al., 2002).  
Sustained stimulation of apoptosis could ultimately result in 
excessive cell loss and ulcer development, while inhibition of 
apoptosis has been reported to be associated with the early 
phases of carcinogenesis. Prolonged survival of abnormal cells 
can favour the accumulation of sequential genetic mutations 
that would result in tumour promotion (Rad et al., 2002 ).  
Moss et al. reported an increased rate of cell proliferation and 
a decrease in the apoptotic index in H. pylori infection (Rad et 
al., 2002). Increased proliferation of epithelial cells is an early 
event observed during H. pylori infection.  
The expression of c-fos (mRNA and protein), which regulates 
the transcription of genes related to cell cycle control, was 
significantly higher in the H. pylori-infected mucosa than in 
normal mucosa and in precancerous lesions (Cover et al., 
1994). Cyclooxygenase-2 (COX-2) interferes with the balance 
between cell proliferation and apoptosis and is also 
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abnormally expressed in the H. pylori-infected mucosa 
(Atherton et al., 1997). Overexpression of COX-2 has been 
detected in H. pylori-positive gastritis, in precancerous lesions 
and in gastric cancer, suggesting an early role of COX-2 in 
gastric carcinogenesis (Atherton et al., 1997). A positive 
correlation between COX-2 expression and the Ki-67 labelling 
index, as well as an inverse correlation between COX-2 
expression and the apoptosis index have been demonstrated 
(Boquet et al., 2003). 
Human stomach carcinogenesis occurs after a multistep 
process originating from epithelial stem cells which is driven 
by the accumulation of molecular alterations involving either 
the suppressor pathway (defect in tumour suppressor genes) 
or mutator pathway (defect in DNA mismatch repair genes) 
(Kuniyasu t al., 2000; 385: 69–74). The scenario of these 
alterations shows different genetic pathways for well-
differentiated or intestinal type and poorly differentiated or 
diffuse type gastric cancers.  
Two mechanisms have been implicated in the molecular 
alterations: genetic and epigenetic.  
The former includes changes in the DNA sequence, the latter 
involves methylation of CpG islands which occurs without DNA 
sequence changes. The most important difference between 
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genetic and epigenetic alterations is that epigenetic changes 
are potentially reversible by eliminating the toxic agents or 
with the use of therapeutic interventions and chemical agents 
(Lengauer et al., 1998).  
The stomach is one of the organs, the epithelial cells of 
which frequently undergo aberrant methylation of CpG 
islands because of direct contact with the environment 
(Kang et al., 2003). Furthermore, H. pylori, infecting the 
gastric mucosa, may induce methylation of promoters 
containing CpG islands by release of ROS and NO and by 
activation of DNA methyltransferase (Tamura et al., 2004).  
Methylation of CpG islands of multiple genes including APC, 
COX-2, DAP-kinase, E-cadherin, GSTP1, hMLH1, MGMT, 
p16, p14, RASSF1A, THBS1, and TIMP3, in precancerous 
gastric lesions have been investigated and it was shown that 
aberrant CpG island methylation tends to accumulate along 
the multistep process of gastric carcinogenesis (Kang et al., 
2003). Elimination of H. pylori infection has the potential to 
induce regression of epigenetic alterations and restore 
normal phenotype (Tamura et al., 2004). An intense survey 
of the literature revealed that precancerous lesions, such as 
atrophy and even intestinal metaplasia or non-invasive 
neoplasia, may undergo regression after eradication of H. 
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pylori infection.  
In fact, intestinal metaplasia and lesions so-called indefinite 
for dysplasia are typical abnormalities of differentiation 
which dependent upon epigenetic changes (El-Zimaity et al., 
1999).  
 
Induction of enzymes and cytokines by H. pylori 
Cox enzymes catalize the conversion of arachidonic acid to 
prostanoids such as prostaglandin E2, which protect the 
gastric mucosa from apoptosis by increasing cell 
proliferation (Gisbert et al., 2003). Two isoenzymes exist: 
COX-1 and COX-2; the former is constituent and the latter 
inducible in case of injury, and mediates inflammation 
among other processes (Halter et al., 2001). H. pylori-
related gastritis has been shown to induce COX-2 
expression according to type of bacterial strain, which may 
in part account for differential pathogenicity (Guo et al., 
2003). Infection by H. pylori cagA + strains has been seen 
to overexpress COX-2 in patients with gastric cancer (Guo 
et al., 2003).  
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Figura 3 COX-2 gene map. 
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In addition, some studies have demonstrated that organism 
eradication is associated with a decreased gastric COX-2 
expression (Konturek et al., 2003). Another molecule, nitric 
oxyde (NO), has been documented to contribute to gastric 
mucosal protection by increasing blood flow and inhibiting 
leukocyte adhesion to the endothelium. There is no 
inducible NO synthase (iNOS) in the normal gastric mucosa, 
but its expression increases in patients with H. pylori-
related gastritis (Fu et al., 1999). Both iNOS and COX-2 are 
induced by cytokines, including IL-1β, tumor necrosis factor 
α, interferon γ, phorbol esters, and growth factors, as well 
as bacterial lipopolysaccharides (Arias-Negrete et al., 1995). 
Epithelial gastric cells substantially contribute to the 
cytokine-induced proinflammatory response to H. pylori 
infection, both through active production and the capture of 
cytokines derived from the lamina propria and 
intraepithelial leukocytes. Epithelial IL-1β, IL-6, IL-8, and 
tumor necrosis factor αlevels have been shown to be 
significantly higher in infected patients versus healthy 
subjects. There is also interferon γ, but not IL-4, 
overexpression in infected patients, which suggests a Th1 
lymphocyte-mediated response. Finally, increased 
interferon γlevels may contribute to gastric inflammation no 
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only through phagocyte and neutrophil activation, but also 
the induction of MHC II overexpression in epithelial cells, 
with an ensuing increase in H. pylori adhesion. 
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AIM OF THIS STUDY  
In this study, we show that histone modifications play a 
pivotal role in H. pylori-induced expression of COX-2 
promoter in the human gastric epithelial cell line NKN28.  
To provide a novel molecular mechanism of COX-2 epigenetic 
regulation in H. pylori infected cells, we whant to 
demonstrate, by modification of chromatin analyses, that the 
induction of COX-2 expression is associated with both 
methylation and acetylation of histones and methylation of 
DNA at the COX-2 promoter,  
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MATERIALS AND METHODS  
Bacterial Strain and Growth Conditions 
We used the urease-positive Tox+ (type s1a/m1 vacA allele) 
CagA+ wildtype H. pylori strain 60190 (American Type Culture 
Collection, Rockville, MD, USA, 49503) and wild-type H. pylori 
strain CCUG 17874 (Tox+ CagA+) (National Collection of Type 
Cultures, London, England, 11638). Bacteria were grown in 
brucella broth (DIFCO Laboratories, Detroit, MI) supplemented 
with 1% Vitox (Oxoid, Basingstoke, United Kingdom) and 5% 
FCS (Life Technologies, Inc., Paisley, United Kingdom) for 24–
36 h at 37°C in a thermostatic shaker under microaerobic 
conditions. Bacteria were harvested by centrifugation, and 
added to gastric cells at concentration of 5x 107 CFU/ml in 
DMEM supplemented with 10% FCS. Cells were incubated in 
the absence (controls) or in the presence of bacteria for 
indicated times. The cells were suspended in phosphate-
buffered saline (PBS) and the density was estimated by 
spectrophotometry (A405) and by microscopic observation. To 
avoid the influence of serum, in all experiments gastric cells 
were serum starved for 16 h before and throughout the period 
of treatment. 
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Human Gastric Epithelial Cells in Culture 
Since a normal human gastric epithelial cell line is not 
available, we used the following human gastric epithelial cell 
lines: MKN 28 cell line, derived from a human gastric tubular 
adenocarcinoma and showing moderate gastric-type 
differentiation (Taplick et al., 2001; Grozinger et al., 2002); 
this cell line has proven to be a suitable in vitro model for the 
study of interactions between H. pylori and gastric epithelium 
(Ricci at al., 1993a; Ricci et al., 1993b; Sommi et al., 1998). 
MKN 28 cells were grown as monolayers in DMEM Ham’s 
nutrient mixture F-12 (1:1; Sigma, St. Louis, MO) 
supplemented with 10% FCS (Life Technologies, Inc.) at 37°C 
in a humidified atmosphere of 5% CO2. 
 
Preparation of cell extracts and Western Blot Analysis 
After incubation with H. pylori, cells were rapidly washed twice 
with PBS to remove bacteria and lysed in RIPA buffer (PBS 
containing 1% Nonidet P 40, 0.5% sodium deoxycholate, 0.1% 
SDS, 100 ng/mL phenylmethyl sulfonyl fluoride and 10µg/mL 
aprotinin). The samples, containing 50 µg protein per lane, 
were resolved by electrophoresis using 12 % SDS-PAGE 
precast gels (Bio-Rad Laboratories, Milan, Italy) as 
appropriate, then transferred to BA 85 0.45 mm PROTAN 
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nitrocellulose filters (Schleicher & Schnell, Inc., Dassel, 
Germany). 
The blots were pretreated in tris-buffered saline containing 
5% non-fat dry milk and 0.1% Tween 20, and then incubated 
with antibody for COX-2 or IkB-alfa (Santa Cruz 
Biotechnology, Santa Cruz, CA, USA). Filters were washed 
three times and then incubated with a horseradish 
peroxidase-conjugated secondary antibody against goat or 
rabbit IgG (Amersham Pharmacia Biotech, Buckinghamshire, 
UK), developed using a commercial enhanced 
chemiluminescence system (ECL, Amersham Pharmacia 
Biotech, Buckinghamshire, UK), and exposed to films 
(Hyperfilm, Amersham Pharmacia Biotech). Immunoblot 
analysis using anti γ-tubulin antisera was performed as a 
control for protein loading. Western blot analyses of each 
sample were performed more than three times. 
 
Real-Time PCR 
Total RNA was isolated from MKN28 cells using an RNeasy 
Mini kit (Qiagen) according to manufacturer’s instructions. A 
reverse transcription-PCR (RT-PCR) procedure was used to 
determine relative quantities of mRNA (QuantiTect Reverse 
Transcription kit, Qiagen). Negative control samples (no first-
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strand synthesis) were prepared by performing reverse 
transcription reactions in the absence of reverse transcriptase. 
Quantitative real-time PCR was carried out with cDNA using 
the QuantiTect SYBR Green (Qiagen), gene-specific primers 
and an Chromo4 Real Time thermocycler (Biorad). The primers 
for all genes tested were described as follows: Glucose-6-
Phosphate Dehydrogenase (G6PD), 5’-
GATCTACCGCATCGACCACT-3’ (sense) and 5’-
AGATCCTGTTGGCAAATCTCA-3’ (antisense); Cyclooxygenase-
2 (COX-2) 5’- TCACGCATCAGTTTTTCAAGA-3’ (sense), 5’-
TCACCGTAAATATGATTTAAGTCCAC -3’ (antisense); Histone 
deacetylase  1 (HDAC-1) 5’-AGCTCCACATCAGTCCTTCCA-3’ 
(sense), 5’-GTGCGGCAGCATTCTAAGGT-3’ (antisense); 
Histone deacetylase 2 (HDAC-2) 5’-
AAACTGCATATTAGTCCTTCAA-3’ (sense) 5’ –
TGAGGTAACATGCGCAAATTTT-3’ (antisense) and Histone 
deacetylase 3  (HDAC-3) 5’-GGAGCTGGACACCCTATGAA-3’ 
(sense) 5’-TATTGGTGGGGCTGACTCTC-3’ (antisense). Gene-
specific primer pairs were designed using Roche Applied 
Science software (http://www.roche-applied-
science.com/sis/rtpcr/upl/adc.jsp). The reaction mixture 
contained 2 µl cDNA, 0.3 µM of primers, and 10 ml of Sybr 
green Mastermix (Qiagen), in a total volume of 20 ml. PCR 
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cycles were as follows: 95°C for 15 min followed by 40 cycles 
of 95°C for 15 s, 58°C for 30 s, and 72°C for 30 s. Each 
reaction was performed in triplicates. Melting curve analysis 
was performed to verify the specificity of products. The 
comparative method of relative quantification (2-DDCt ) method 
(Livak et al., 2001) was used to calculate expression levels of 
each target gene, normalized to the housekeeping gene G6PD. 
The data are presented as fold changes in gene expression. At 
least three independent experiments were performed and 
results are expressed as averages ± S.M. 
  
HDAC activity assay 
Assays were performed using the colorimetric HDAC activity 
assay (Upstate) according to manufacturer’s instructions. 
Briefly, 50 μg of nuclear extracts from MKN28 cells, infected 
with Hp at different times, were diluted in 85 μL of ddH2O; 
then, 10 μL of 10× HDAC assay buffer were added followed by 
addition of 5 μL of colorimetric substrate; samples were 
incubated at 37°C for 1 h. Subsequently, the reaction was 
stopped by adding 10 μL of lysine developer and left for 
additional 30 min at 37°C. Samples were then read in an ELISA 
plate reader at 405 nm. HDAC activity was expressed as 
relative OD values per μg of protein sample. The kit contains 
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negative and positive controls, that is, nuclear extract of HeLa 
treated and untreated with trichostatin A, respectively. 
 
Chromatin immunoprecipitation (ChIP) assay 
Cross-linking was performed by adding 1% formaldehyde 
directly into tissue culture dishes containing 3 X 106 MKN28 at 
different time points after Hp infection, followed by incubation 
at room temperature for 10 min. Cells were washed twice with 
PBS, collected, and pelleted by centrifugation at 400 g for 5 
min. The pellets were resuspended in sonication buffer 
(containing 50 mM Tris-HCl, pH 8.1, 10 mM EDTA, 1% SDS, 
and protease inhibitors) and incubated in ice for 10 min to 
lyse the nuclei. Nuclear extracts were then sonicated to obtain 
400-800 bp fragments of chromatin using a 3 mm tip 
equipped Bandelin Sonoplus UW-2070 sonicator (small size). 
Immunoprecipitation was carried out according to the protocol 
provided by Upstate Biotechnology (Lake Placid, NY, USA). 
Briefly, chromatin was diluted10-fold in ChIP dilution buffer. A 
small amount of chromatin was kept aside at this step to be 
used as input control in subsequent PCR reactions. Antibodies 
anti-dimethyl-histone H3K4, anti-dimethyl-histone H3K9, 
anti-tri-methyl-histone-H3K27, antiacetyl-histone-H3, 
antiacetyl-histone-H4 (Abcam), anti-HDAC1, anti-HDAC2, 
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anti-RNA-polymerase II, and anti-NFKB (p65) (Santa Cruz) 
were incubated with diluted chromatin at 4°C overnight. 
Immunoprecipitations were also carried out with no Ab 
controls. Protein A Sepharose (Amersham Biosciences), 
blocked with sheared salmon sperm DNA, was used to collect 
Ab-chromatin complexes. Immune complexes were then 
washed once with low salt immune complex wash buffer 
(containing 0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM 
Tris-HCl, pH 8.1, 150 mM NaCl), once with high salt immune 
complex wash buffer (containing 0.1% SDS, 1% Triton X-100, 2 
mM EDTA, 20 mM Tris-HCl, pH 8.1500 mM NaCl), once with 
LiCl immune complex wash buffer (0.25M LiCl, 1% IGEPAL-
CA630, 1% deoxycholic acid, 1 mM EDTA, 10 mM Tris-HCl, pH 
8.1), and twice with sterile TE buffer. 
The chromatin (histone-DNA complexes) were eluted with 
freshly prepared elution buffer (containing 1% SDS and 0.1M 
NaHCO3), followed by reverse cross-linking with 0.3M NaCl at 
65°C for 4–5 h. DNA fragments were then purified with 
QIAquick spin column followed by semiquantitative PCR and 
Real Time PCR amplification. The primers for the COX-2 
promoter, used for conventional PCR were: 
5'GGCAAAGACTGCGAAGAAGA3' and 
5'GGGTAGGCTTTGCTGTCTGA 3'. The PCR product covers DNA 
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sequence from -320 to +107 and contains NF-kB, cyclic AMP 
response element (CRE), CCAAT-enhancer binding protein 
(C/EBP), and TATA cis-elements in the promoter region. 
Initially, PCR was performed with different numbers of cycles 
or dilutions of input DNA to determine the linear range of the 
amplification; all results described fall within this range. The 
PCR conditions used were: initial denaturation at 95°C for 2 
min followed by 30 cycles of 95°C for 30 s, 55°C for 30 s, and 
72°C for 30 s. The PCR products were separated on a 1.4% 
agarose gel and stained with ethidium bromide. Alternatively, 
recovered DNA was subjected to quantitative real-time PCR as 
described above.  
 
Quantification of ChIP DNA by real-time PCR.  
Immunoprecipitated DNA recovered from ChIP were 
quantizated by real-time PCR using a 7500 Chromo4 Real 
Time thermocycler (Biorad). The primers for the COX-2 
promoter, used for real-time PCR were: 5’ 
AAGGGGAGAGGAGGGAAAAATTTGTG 3’ (sense) and 5’ 
GAGGCGCTGCTGAGGAGTTCCTG 3’ (antisense). The reaction 
mixture contained 2 µl of ChIP or input DNA, 0.3 µM of 
primers, and 10 ml of Sybr green Mastermix (Qiagen), in a 
total volume of 20 ml. PCR cycles were as follows: 95°C for 15 
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min followed by 40 cycles at 95°C for 15 s, 62°C for 30 s, and 
72°C for 30 s. Input DNA was the unbound fraction of the 
non-immunoprecipitated sample. Melting curve analysis 
revealed a single PCR product. Serial dilutions of input DNA 
revealed that PCR results were linear from 100 ng to 0.1 ng 
and were used to calculate absolute amounts of PCR products. 
Results are represented as input percentage and calculations 
take into account the values of minimum three independent 
experiments.  
 
Methylation DNA analysis with MALDI-TOF MS.  
The modification with sodium bisulfite was followed by the 
amplification COX-2 promoter region with the application of 
primers containing a fragment of T7 promoter. The product, 
including CpG sites, was transcribed in vitro, creating a 
mosaic DNA/RNAstructure and cut with RNaseAin the way 
depending on U or C bases.  Mass signals transmitted by DNA 
molecule was analyzed in Matrix-assisted 
laserdesorption/ionization time-toflight mass spectrometry 
(MALDI-TOF MS). The relation between the methylated and 
unmethylated DNA was established by comparing the intensity 
of signals sequences, which is achieved by means of using 
different fluorescent dyes (VIC and FAM)  
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Statistics analysis 
Three separate experiments carried out in duplicate were 
performed and average values and standard errors (S.M) were 
calculated. 
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RESULTS 
 
H. pylori infection induces activation of COX-2 gene  
H. pylori infection of gastric mucosa leads to activation of 
COX-2 gene (Takahashu et al. 2000).  
In order to investigate the early transcriptional events 
occurring at the human COX-2 promoter gene upon induction 
by H. pylori, the human gastric epithelial cell line MKN28 has 
been taken as a model. MKN28 cells were grown to 
confluence, incubated with bacterial suspension of the H. 
pylori 60190 (wild-type) strain and then the levels of COX-2 
mRNA were measured. As expected, a time-dependent 
increase of COX-2 mRNA in response to H. pylori infection 
was found (Figure 4A). The increase in COX-2 mRNA 
expression showed a first peak after 60 minutes of infection 
and a second more pronounced peak at 12 hours, before 
declining at 24 hours (Figure 4A). Similar experiments using a 
different strain of H. pylori (strain CCUG 17874) gave 
comparable results (data not shown) showing that the 
observed pattern of COX-2 induction was not related to a 
specific strain of H. pylori. Western Blot analyses showed that 
levels of COX-2 protein increased following a pattern 
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consistent with the one predicted by the mRNA levels over the 
same time course (Figure 4B).  
 
Figure 4 H. pylori induces expression of the COX-2 gene. 
MKN28 cells were grown to confluence and infected with H. 
pylori for 15, 30, 60 min and 2, 4, 6, 12, 24 and 48 hours. (A) 
Total RNA was isolated and used in real-time PCR reactions 
which were evaluated for COX-2 and GAPDH levels. The COX-
2 levels were evaluated relative to time point 0 (Control) and 
normalized to GAPDH levels. Data points represent the 
average of triplicate determinations +/- SD. Similiar results 
were obtained in 3 independent experiments. (B) Lysate were 
collected in RIPA buffer and 50 mg of protein samples were 
loaded for electrophoresis. The expression levels of COX-2 
were detected using antibody against COX-2. The levels of γ-
tubulin were used to demonstrate equal loading. Relative 
values represent the average of three independent 
experiments +/- SD. 
 53 
Role of histone acetylation on H. pylori-induced COX-2 
expression 
In order to test the involvement of histone acetylation on the 
H. pylori-induced COX-2 expression, we pretreated MKN28 
cells with an inhibitor of histone deacetylases (thricostatin, 
TSA) and measured COX-2 mRNA levels by real time PCR 
(Figure 5). Both basal and H. pylori-induced COX-2 mRNA 
levels showed a two-fold increase upon TSA treatment 
indicating a role of histone acetylation state in COX-2 gene 
regulation. We then measured the levels of HDAC1, -2, and -3 
mRNAs after H. pylori infection. Constitutive expression of 
HDAC1, -2, and -3 mRNA was detectable in untreated MKN28 
cells (Figure 6A-C). Interestingly, H. pylori infection induced a 
marked time-dependent reduction in the level of HDAC1 and -
3 in these cells, which was evident after 4 hours and 
progressed at 12 hours post-infection. HDAC2 mRNA levels 
reduced after 6 hours and then slightly rose after 12 hours of 
H. pylori infection. Then, we analyzed the global HDAC activity 
in nuclear extracts of MKN28 cells exposed or not to H. pylori. 
We found a time-dependent decrease of HDAC activity in 
exposed cells compared to non-exposed MKN28 (Fig. 6D). 
Taken together, these data show that H. pylori-induced 
transcriptional activation of COX-2 gene expression in gastric 
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epithelial cells is accompanied by reduction of HDAC1, -2 and 
-3 expression and of global histone deacetylase nuclear 
activity. 
 
Figure 5 Prevention of histone deacetylation with TSA 
increased H. pylori-induced COX-2 expression. MKN28 
cells were treated with TSA (100ng/ml), H. pylori, or H. pylori 
+ TSA for 12 hours. Total RNA was isolated and used in real-
time PCR reactions which were evaluated for COX-2 and 
GAPDH levels. The COX-2 levels were evaluated relative to 
control and normalized to GAPDH levels. Data points 
represent the average of triplicate experiments +/- SD.  
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Figure 6 H. pylori exposure down-regulate HDAC1, 2, and 
3 expression and global HDAC activity. (A-C) MKN28 cells 
were grown to confluence and exposed to H. pylori for 0, 4, 6, 
and 12 hours. Total RNA was isolated and used in real-time 
PCR reactions which were evaluated for HDAC1 (A), HDAC2 (B), 
HDAC3 (C) and GAPDH mRNA levels. The HDAC-1, 2 and 3 
mRNA levels were evaluated relative to time point 0 and 
normalized to GAPDH levels. Data points represent the 
average of triplicate experiments +/- SD. (D) HDAC activity 
assays were performed in MKN28 cells after exposure to H. 
pylori for 0, 4, 6 and 12 hours. The HDAC activity was 
measured in triplicate with a HDAC colorimetric histone 
deacetylase activity assay kit (Upstate Biotechnology). H20 was 
used as negative control. TSA-treated Hela cells served as 
positive control. Data are expressed as relative OD values per 
μg of protein sample and are presented as average of three 
independent experiments +/- SD. 
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Role of histone acetylation induced by H. pylori 
In order to determine whether decreased HDAC activity and 
expression correlated with an increase in acetylated histones 
H3 or H4, in the promoter region of COX-2 induced by H. 
pylori in MKN28 cells, ChIP analysis was performed. Cells were 
incubated with H. pylori for different time points and 
chromatin was then immunoprecipitated with an antibody 
raised against acetyl H3 and H4. We found that upon infection 
of MKN28 with H. pylori, the acetylation in histone H3 reveal a 
transient pattern at the promoter of COX-2 gene. In fact, the 
histone H3 is acetylated at 6h time point with maximum 
detection at 12h, loses this modification after 24h, but then 
regains it at 48h (Figure 7A). Hyper-acetylation of histone H3 
is in agreement with expression of the COX-2 gene. This 
pattern reflects the one of H3-K4 dimethylation (Figure 9A), 
and these two modifications are likely to act together to form 
a post-activation signal. In contrast, histone H4 was 
constitutively acetylated and remained almost unchanged 
following H. pylori infection (Figure 7B). These two types of 
positive histone modifications, H3 acetylation and H3-K4 
dimethylation, are selectively present at the COX-2 promoter, 
activating its gene expression in gastric epithelial cells after 
infection with H. pylori. 
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Figure 7 H. pylori induces acetylation of histone H3 in the 
promoter region of COX-2. Chromatin from MKN28 cells was 
harvested 0, 30, 120 min, and 6, 12, 24 and 48 h after 
infection with H. pylori. Results are shown from ChIP analyis 
using anti-acetyl-H3 (A) or anti-acetyl-H4 antibodies (B). 
Recovered DNA sequences were quantified by real-time PCR 
using primers described in Fig. 4A. Average % input recoveries 
and +/- S.D. from 3-4 independent experiments are plotted. 
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Effect of H. pylori on the recruitment of HDAC-1 and 
HDAC-2 to the COX-2 promoter 
Since the expression of COX-2 induced by H. pylori, in MKN28 
cells correlates with increased histone H3 acetylation, we 
hypothesized that H. pylori infection might mediate this effect 
by reducing recruitment of HDACs to the COX-2 promoter. To 
test this hypothesis, we performed ChIP assays, and the 
immunoprecipitated DNA was quantified by semi-quantitative 
PCR. Results reveal that the 2 HDACs were readily detected at 
the COX-2 promoter (Figure 8B). 6h after infection by H. 
pylori, we observed a release of HDAC1 from the COX-2 
promoter, but no effect on the HDAC2 levels. These results 
show that the increase in histone H3 acetylation and the 
induction of COX-2 transcription by H. pylori involve release 
of HDAC-1 from COX-2 promoter. 
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Figure 8 Time course of H. pylori-induced binding of HDAC-1 
and -2, NFk-B (p65) and RNA Polymerase II at the COX-2 
promoter. (A) Chart of the COX-2 promoter showing the locations 
of PCR primer used for ChIP assay. (B and D) MKN28 cells were 
grown to confluence and infected with H. pylori at indicated times. 
Chromatin was harvested and precipitated with anti-HDAC-1, anti-
HDAC-2 (B), anti-NFk-B(p65) or anti-RNA-Pol II antibodies (D). 
After DNA recovery the precipitates were evaluated by conventional 
semi-quantitative PCR with COX-2 promoter primers (A). PCR 
products were separated by agarose gel electrophoresis and 
detected by ethidium bromide staining. PCR amplifications of the 
COX-2 promoter of the total DNA (without prior immune 
precipitation) were used as control (Input DNA).(C) IkB-alfa protein 
levels were detected with a specific antibody in Western blot and 
simultaneous detection of γ-tubulin demonstrated equal protein 
load. Representative gels of three separate experiments are shown 
in B-D. 
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Histone Methylation at H. pylori induced COX-2 gene 
To determine whether induction of the COX-2 gene upon Hp 
infection is accompanied by modification of the histone 
methylation state at the COX-2 promoter, antibodies against 
dimethylated H3K9 (H3K9me2), dimethylated H3K4 
(H3K4me2) and trimethylated H3K27 (H3K27me3) were used 
in ChIP assays. For this purpose, MKN28 were infected with H. 
pylori at different time points and chromatin was prepared for 
ChIP analysis. COX-2 promoter region examined in these 
assays is shown in Figure 8A. We found that H3K9me2 had 
significantly decreased in gastric epithelial cells 12 hours after 
H. pylori infection and gradually returned to its basal state at 
48 hours (Fig. 9B). H3-K9 methylation serves as a signal for 
chromatin silencing by recruiting the HP1 protein 
(heterochromatin protein 1) and these results suggest that the 
increased COX-2 expression seen in the H. pylori -infected 
MKN28 may be due to a loss of this repressive epigenetic 
histone modification. In contrast, we found that H3K4me2 
levels were low in non-infected gastric cells, while 
significantly increased at 12 hours after H. pylori infection 
returning to a nearly basal level after 48 hours (Figure 9C). 
These results are in agreement with the repressive role of 
H3K9me2 and with the positive role described for H3K4me2 in 
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gene transcription (Lachner and Jenuwein, 2002). 
 
Figure 9 H. pylori induces methylation of histone H3 in 
the promoter region of COX-2. (A) Chart of the COX-2 
promoter. Locations of the primers used for evaluating anti-
histone modification ChIPs are shown below the line. Primer 
positions shown indicate 5’ position of the forward primer 
relative to the transcription start site. Chromatin from MKN28 
cells was harvested 0, 30, 120 min, and 6, 12, 24 and 48 h 
after infection with H. pylori. Results are shown from ChIP 
analyis using anti-dimethyl-H3-K9 (B), anti-dimethyl-H3-K4 
(B) or anti-trimethyl-H3-K27 (B), antibodies. Recovered DNA 
sequences were quantified by real-time PCR. Average % input 
recoveries and +/- S.D. from 3-4 independent experiments 
are plotted. 
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Methylation of H3-K27 has been associated to active 
processes leading to gene silencing. Surprisingly, we found 
that upon infection of MKN28 with H. pylori, the H3-K27 
residues remained almost unchanged at 6h, but then 
significantly increased at 12 h, suggesting an inverse 
correlation with COX-2 expression. 
 
CpG methylation of COX-2 promoter 
Dynamic variations in the methyaltion status of some CpGs 
was evaluated trough MALDI-TOF MS technique (Sequenom) 
before (time 0) and after infection with Hp for 2 h. About 50 
CpGs have been analyzed. Ten more representatives are 
shown in Figure 10. Within the 8 CpGs located between -
176/+244 of the COX-2 promoter, all exhibit kinetic changes 
of the methylation status. All the cytosines located on the 
upper strand are methylated at 20-25 min, undergo 
demetylation at 50-55 min and then remethylate. The 
methylation status of the CpGs on the bottom strand is more 
variable. All the CpGs examined are continually demetylated 
and remethylated. 
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Figure 10 Methylation status of the the COX-2 promoter. 
Methylation status of individual CpG on upper (coding) and bottom 
(transcribed) strands as determined by MALDI-TOF MS technique. 
“Time 0” refers to initial methylation status before H. pylori 
infection. 
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NF-kB associates with COX-2 promoter upon H. pylori 
infection 
Because COX-2 promoter contains potential binding sites for 
NF-kB transcription factor (Appleby et al., 1994), possible 
association of NF-kB with COX-2 gene during Hp infection has 
been investigated through ChIP assays.  
ChIP assays were performed at different times after Hp 
infection using anti-p65 antibodies, followed by semi-
quantitative PCR analyses with specific primers amplifying the 
COX-2 promoter region (from -320 to +107) containing a NF-
kB binding sites (Figure 7A). We observed that the binding of 
p65 to COX-2 promoter occurred starting 30 min after H. 
pylori infection (Figure 7B). Detection of p65 peaked before 
maximal COX-2 mRNA accumulation (12 hours) and appeared 
to be transient, with enrichment levels falling at 4 hours. 
Accordingly, Western blot analysis of IkB-a, a NF-kB inhibitor, 
proved that the levels of such protein decreased starting from 
60 minutes and were restored after 6 hours of H. pylori 
infection (Fig. 7C). ChIP assays were then performed on the 
same samples using anti Pol II antibodies. Interestingly, RNA 
polymerase II loaded onto the COX-2 promoter after 6 hours 
and disappeared after 24 hours (Figure 7B). These results 
suggest that the first peak of COX-2 mRNA levels detected at 
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1 hour following hp infection (Fig. 4), may be due to post-
transcriptional events while the later peak (12 hours) was 
primarily transcriptional.  
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DISCUSSION 
 
Emerging data suggest that bacteria are able to provoke 
histone modifications and chromatin remodelling in infected 
cells, thereby altering the host’s transcriptional program 
(Hamon et al 2008). In this study, for the first time the effect 
of H. pylori is described on chromatin modification of the 
COX-2 promoter in the human gastric epithelial cell line 
MKN28.  
Firstly, we examined mRNA and protein expression levels of 
COX-2 and the effects of H. pylori stimulation on the MKN28 
cells. The MKN28 cells weakly expressed COX-2 mRNA and 
proteins under the unstimulated condition with H pylori, and 
these expression levels increased dramatically with H pylori 
stimulation (Figure 4A and B). The COX-2 expression has been 
demonstrated in H pylori-associated acute and chronic 
gastritis, and is correlated with chronic inflammatory cell 
infiltration (Fu et al., 1999; McCarthy et al., 1999; Romano et 
al., 1998). Our results concerning induction of COX-2 by H 
pylori are in line with these reports.  
Next, we provided evidence that H. pylori strain 60190-
induced expression of the COX-2 gene is controlled by 
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histone modifications in the MKN28 cells. H. pylori induced 
methylation of H3-K4-me2, H3-K9-me2, H3-K27-me3 and 
acetylation of histone H3 specifically at the COX-2 gene 
promoter. These changes are accompanied by coactivator 
recruitment and chromatin remodelling. This is indicative of 
dynamic chromatin remodelling being triggered by H. pylori. 
Chromatin alteration is shown to control the expression of 
COX-2, which might explain the known effects of H. pylori on 
inflammation, tissue damages, and gastric tumorigenesis. H. 
pylori infection induces inflammation in gastric mucosa, which 
causes chronic gastritis (Blaser MJ et al., 1998). Gastritis may 
progress to gastric atrophy (GA), intestinal metaplasia (IM), 
and gastric cancer (GC). It may also result in monoclonal 
lymphocyte proliferation, lymphoid follicle (LF) development, 
and later primary gastric lymphoma (PGL). These precancerous 
lesions develop only in a proportion of subjects affected by 
gastritis because of multifactorial effects of bacterial virulence 
and host factors that vary among different ethnic groups (Lee 
et al., 2005). Among host factors, several inflammatory 
proteins including cytokines, growth factors, and chemokines 
have been known to control adaptive and innate immune 
response against H. pylori infection (Rad et al., 2004; 
Macarthur et al., 2004).  
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COX-2 is an inducible enzyme, catalyzing conversion of 
arachidonic acid to prostaglandins in response to various 
inflammatory stimuli (Herschman 1996). Up-regulation of 
COX-2 plays a central role in the inflammatory changes and 
tissue damage associated with chronic H. pylori infection and 
is also involved in gastric tumorigenesis (Harris et al., 2005; 
Willhite et al., 2003). Understanding the mechanisms by which 
Cox-2 expression is regulated could provide insight into how 
its expression increases in diseased tissue, and may also 
suggest targets for novel pharmacological agents aimed at 
suppressing its expression. The regulation of Cox-2 gene 
expression has been studied by several groups, and there 
have been reports of regulation at a number of different steps 
(Ramsay et al., 2003). In addition to the transcriptional 
regulation of the gene, increasing evidence shows that histone 
modifications may be important for the transcriptional activity 
state of genes by loosening the DNA-histone interaction and 
unmasking of transcription factor binding sites. Transcription 
repression or gene activation is regulated by specific covalent 
modifications of accessible N-terminal histone tails (Strahl et 
al., 2000; Nightingale et al., 2006), including acetylation 
(mostly lysine), phosphorylation (serine/threonine), and 
methylation (lysine) (Claus et al., 2003, Jenuwein et al., 2001). 
 69 
The N-terminal tails of H3 and H4 can be methylated at 
several lysine and arginine residues that are linked to either 
transcriptional activation or repression. For example, 
methylated H3-K9 provides a specific interaction site for the 
heterochromatin protein 1 (HP1) proteins, which are 
implicated in transcriptional repression and in establishing 
and maintaining heterochromatin (Bannister et al., 2001; 
Lachner et al., 2002; Hwang et al., 2001). Interestingly, a 
common pattern of H3-K9 methylation occurs in a subset of 
inducible inflammatory genes (Saccani and Natoli, 2002). This 
pattern is characterized by a loss of constitutive levels of H3-
K9 methylation after activation followed by a restoration of 
methylation concurrent with post-induction transcriptional 
repression. Dynamic changes in the methylation of the COX-2 
promoter did occur after induction of the gene. In the COX-2 
promoter there are constitutive levels of H3-K9 methylation, 
which significantly decreased 12 h after Hp infection and 
returned to its basal at 48h (Figure 4A). Lysine 4 of histone H3 
can be di- or trimethylated. Trimethylation is associated with 
actively transcribed genes, whereas dimethylation is 
associated with both silent and active genes. Our results show 
that histone H3-K4 dimethylation occurs at the promoter 
region of COX-2 and persists at the 12-time point. This is 
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consistent with studies suggesting that H3-K4 methylation is 
a marker of recent transcription. Trimethylation of H3K27 is a 
facultative heterochromatin mark that promotes recruitment 
of Polycomb group proteins for gene silencing (Czermin et al., 
2002; Orlando, 2003). Interestingly, in MKN28 cells, 
H3K27me3 is almost unchanged at 6h and significantly 
increases at 12h. Several loci in both ES and adult stem cells, 
including those encoding key developmental regulators, are 
characterized by the simultaneous presence of H3-K4me3 and 
H3-K27me3, a configuration described as “bivalent domain” 
(Bernstein et al., 2006). In undifferentiated ES cells this 
unusual combination of marks is thought to keep genes 
repressed or expressed at very low levels though ready for 
later activation (Bernstein et al., 2006), which implies a 
functional dominance of the inhibitory mark (H3K27me3) over 
the active one (H3K4me3). In differentiated cells bivalent 
domains may have a more complex function in fine-tuning 
gene expression, as suggested by a genome-wide analysis in 
T lymphocytes (Roh et al., 2006). The same model has been 
proposed for the Bmp-2 gene promoter in macrophages.  
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Figura 11 Schematic representation of the model for 
epigenetic regulation of COX-2 promoter in gastric 
epithelial cells upon infection with H. pylori. See 
“Discussion” for details.  
 
 
Hypoacetylation and deacetylation of histones, respectively, 
lead to tighter winding of DNA and reduced gene 
transcription. HDACs are known to decrease acetylation of 
individual lysines of histones H3 or H4 relevant in gene 
transcription (Ito et al., 2002). The proposed relation between 
H. pylori-infection and HDACs was supported by studies that 
made use of TSA, a specific inhibitor of HDAC activity, for 
COX-2 expression. Preventing histone deacetylation clearly 
increased the COX-2 mRNA expression in H. pylori-infected 
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gastric cells (Figure 5). Moreover, we demonstrated that H. 
pylori reduced the global expression and activity of class I 
HDAC1, 2 and -3 in gastric epithelial cells, indicating an 
important role of HDACs in regulation of COX-2 expression 
(Figure 4A, B, C and D). Another well-described mark, 
acetylation, which is also a modification found on lysine 
residues, has been mostly shown as associated with active 
transcription. It is thought to render chromosomal domains 
more accessible to the transcriptional machinery. Recent 
studies demonstrate that histone acetylation is implicated in 
the induction of COX-2 transcription (Soloff et al., 2004; Nie 
et al., 2003; Park et al., 2004; Miao et al., 2004). Interestingly, 
in the present study we found that H. pylory increased histone 
H3 acetylation at the COX-2 promoter, but had no significant 
effect on the level of histone H4 acetylation (Figure 7A and B). 
In particular, the ChIP studies of the pattern of histone 
acetylation across the COX-2 promoter revealed a rapidly 
inducible acetylation of histone H3, followed by deacetylation 
as the level of mRNA declined (Figure 7A). To our knowledge, 
this is the first study to prove that H. pylori selectively 
modulates the level of histone acetylation at the COX-2 
promoter. These results also suggest that the pattern of 
histone H3, rather than histone H4, acetylation at the COX-2 
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promoter may be more indicative of the changes in COX-2 
transcription. In order to focus on the molecular mechanisms 
responsible for the increase of histone H3 acetylation by H. 
pylori, we hypothesized that H. pylori determines COX-2-
induced histone acetylation by inhibiting recruitment of 
HDACs to the COX-2 promoter. Such a regulatory mechanism 
has been demonstrated for the p21WAF1 promoter. As a matter 
of fact, our ChIP analysis reveal a release of HDAC-1 from the 
COX-2 promoter that might explain the induction of histone 
H3 acetylation by H. pylori (Figure 8B). Though further 
investigation is recommended, these results strongly suggest 
that the effect of H. pylori on induced COX-2 expression is 
mainly mediated by an HDAC-dependent mechanism. The 
COX-2 promoter contains cis-elements for multiple 
transcription activators including NFk-B, NF–IL-6, AP-1, CRE-
binding protein and C/EBP (Appleby et al., 1994). Different 
external stimuli use a combination of different cis-elements in 
the COX-2 gene promoter to activate its expression by 
activation of a specific group of transcription factors (Deng et 
al., 2003; Inoue et al., 1995). The cis-elements used to drive 
COX-2 gene expression in response to H. pylori infection are 
not yet determined. Nonetheless, it has been suggested that 
the increased COX-2 production in H. pylori-infected gastric 
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mucosa is mediated through a NF-κB pathway (Wu et al., 
2005). In resting cells, IB molecules sequester NFk-B in the 
cytosol. After cell activation, a complex signalling cascade 
containing IKK kinase results in degradation of IB, thus 
allowing transfer of NFk-B into the nucleus (Chun et al., 
2004). Thus, in order to analyze more directly the influence of 
H. pylori on NFk-B dependent COX-2 transcription, we 
performed ChIP assays. We found degradation of IB and an 
increased recruitment of the NFKB subunit p65/RelA as well as 
of RNA polymerase II to the COX-2 promoter in H. pylori-
infected epithelium, thus enhancing COX-2 gene transcription 
(Figure 8C and D). These data imply a crucial involvement of 
NFk-B in H. pylori-caused COX-2 induction. Of great interest 
is the observation that the histone H3 residues are acetylated 
at 12 h post-infection (Figure 7A). At this time point, RNA 
polymerase II is no longer detectable on the promoter, 
suggesting that its release occurs regardless extensive histone 
deacetylation. Moreover, RNA polymerase II recruitment, 
hence gene transcription in general, starts only when NFk-
B/RelA approaches the promoter. A proposed model of action 
for H. pylori in regulation of COX-2 is outlined in Figure 11. In 
non-infected gastric cells there are low levels of H3-K4-me2, 
H3-K27-me-3 and H3 acetylation at the COX-2 promoter, 
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due to the action of demethylases and histone deacetylases. 
Infection with Hp transiently down-regulates demethylases 
and HDACs activity and causes an increase in histone 
methyltransferases (MLL1, SUV39H1,-2, G9a, GLP..) and 
acetyltransferares (p300/CBP, PCAF). Consequently, histone 
methylation (H3-K4 and H3-K27) and acetylation (H3) 
increase, NFk-B and Pol II are recruited and this, in turn, 
facilitates transcriptional activation. Subsequently, 
methtylation (H3-K4) is diminished, recruitment of HDAC-1 is 
increased, and HDAC-1 acts to deacetylate histone H3 and 
shut down gene expression with consequent release of NFk-b 
and Pol II. In this model, methylation of H3-K27 may have a 
role in keeping COX-2 gene repressed or expressed at very 
low levels though ready for later activation (Bernstein et al., 
2006). 
In conclusion, our study provides novel data on important 
molecular mechanisms, that were used by H. pylori to activate 
gastric epithelial cells to affect COX-2 transcription, resulting 
in a strong inflammatory response. After H. pylori infection, 
we found alterations in histone pattern and modification, 
reduction of global HDAC expression and activity as well as 
release of HDAC-1 from the COX-2 promoter. Concurrently, 
histone modifications is accompanied by increased 
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recruitment of NFk-B and RNA Pol II towards the promoter. A 
better understanding of the mechanisms involved in H. pylori-
mediated COX-2 induction may help to develop new strategies 
to modify the pathophysiology of inflammatory and tumoral 
diseases caused by COX-2 overexpression. 
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